Registrieren
Registierung erfolgt in Kürze...
Details werden geladen...
One Biosciences Receives BOOST Funding From Paris-Saclay Cancer Cluster to Advance the First Single-Cell Assay Approach for ADC Therapies
One Biosciences, a techbio company pioneering clinical-grade single-cell tumor profiling, today announced financial support via a Paris-Saclay Cancer Cluster (PSCC) BOOST grant to develop the first
Ähnliche Seiten
NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer | The Manila Times
https://www.manilatimes.net/2026/06/16/tmt-newswire/globenewswire/novabridge-biosciences-receives-fda-fast-track-designation-for-givastomig-in-first-line-her2-negative-metastatic-gastric-cancer/2366382
Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL | The Manila Times
https://www.manilatimes.net/2026/06/10/tmt-newswire/globenewswire/cellectis-receives-fda-rmat-designation-for-lasme-cel-the-first-allogeneic-car-t-therapy-in-a-pivotal-trial-for-patients-with-rr-b-all/2362191